First trimester determination of adverse pregnancy outcome

Similar documents
Differentiation between normal and abnormal fetal growth

Assessment of Fetal Growth

A. Evidence for an individually adjustable standard to assess birth weight:

What women can do to optimise their health during pregnancy and that of their baby Claire Roberts

AUSTRALIA AND NEW ZEALAND FACTSHEET

49. INFANT MORTALITY RATE. Infant mortality rate is defined as the death of an infant before his or her first birthday.

Exceptional People. Exceptional Care. Antenatal Appointment Schedule for Normal Healthy Women with Singleton Pregnancies

OET: Listening Part A: Influenza

68 3,676, making progress

Doppler Ultrasound in the Management of Fetal Growth Restriction Chukwuma I. Onyeije, M.D. Atlanta Perinatal Associates

150 7,114, making progress

Future. pathophysiology of preeclampsia. ? hypoxia. Also in. marker. 1st trim. In combi w PE s.flt-1 -- seng, PlGF, VEGF, US. Manifest.

Analytical goal setting in aneuploidy screening: within person biological variability of first trimester biochemical markers

METHODOLOGICAL ISSUES IN THE MEASURES OF MATERNAL MORBIDITY MORTALITY (MM 1 MM 2 ) Dr. AKO Simon

Prediction of Pregnancy Outcome Using HCG, CA125 and Progesterone in Cases of Habitual Abortions

Appendices Bexar County Community Health Assessment Appendices Appendix A 125

SAMPLE. UK Obstetric Surveillance System. Management of Pregnancy following Laparoscopic Adjustable Gastric Band Surgery.

BUTTE COUNTY PUBLIC HEALTH DEPARTMENT POLICY & PROCEDURE

The Influence of Infant Health on Adult Chronic Disease

117 4,904, making progress

Assessing quality of NHS Numbers for Babies data and providing gestational age statistics

Applications of Doppler Ultrasound in Fetal Growth Assessment. David Cole

Institute of Applied Health Sciences. University of Aberdeen DATABASE REVIEW. Grampian University. Hospitals NHS Trust GRAMPIAN DIABETES

Lecture 12a: Complications of Pregnancy

Graviditet och obesitaskirurgi:

Supplementary online appendix

Pregnant and Parenting Youth in Foster Care in Washington State: Comparison to Other Teens and Young Women who Gave Birth

LEUKODYSTROPHY GENETICS AND REPRODUCTIVE OPTIONS FOR AFFECTED FAMILIES. Leila Jamal, ScM Kennedy Krieger Institute, Baltimore MD

Graviditet och obesitaskirurgi:

Major roles of neurocognitive developmental center are as follows:

Effects of Pregnancy & Delivery on Pelvic Floor

PERINATAL NUTRITION. Nutrition during pregnancy and lactation. Nutrition during infancy.

This document covers the principles behind Gestation Adjusted Optimal Weight (GROW) for the following applications

Lecture 2 Conception and Pregnancy Loss

Second-trimester maternal serum alpha-fetoprotein elevation and its association with adverse maternal/fetal outcome: ten years experience

MANA Home Birth Data : Consumer Considerations

Maternity Care Primary C-Section Rate Specifications 2014 (07/01/2013 to 06/30/2014 Dates of Service)

Quality of Birth Certificate Data. Daniela Nitcheva, PhD Division of Biostatistics PHSIS

Behavioural change in relation to alcohol exposure in early pregnancy and impact on perinatal outcomes - a prospective cohort study

Reduced Ovarian Reserve Is there any hope for a bad egg?

INTERGROWTH-21 st International Fetal and Newborn Growth Standards for the 21 st Century

Executive Summary. Evaluating the Family Nurse Partnership programme in England: The Building Blocks randomised controlled trial

Denver County Births and Deaths 2013

Effect of Increased Body Mass Index on the Accuracy of Estimated Fetal Weight by Sonography in Twins

Risk Calculation Software Requirements for Down's Syndrome Screening

POLYCYSTIC OVARY SYNDROME

European IVF Monitoring (EIM) Year: 2008

Endocrinology of the Female Reproductive Axis

Ultrasound of Fetal Biometrics and Growth

Behavioural change in relation to alcohol exposure in early pregnancy and impact on perinatal outcomes a prospective cohort study

Parvovirus B19 Infection in Pregnancy

First Trimester Screening for Down Syndrome

Women Who Quit Smoking During Pregnancy

Standard Comparison Protocols at NICU, Regional and National levels.

SWISS SOCIETY OF NEONATOLOGY. Umbilical cord complications in two subsequent pregnancies

Crohn's disease and pregnancy.

Ronna L. Chan. Chapel Hill Approved by: Sandra L. Martin, Ph.D. (Chair, Academic Advisor) Andrew F. Olshan, Ph.D. (Co-Research Advisor)

Disclosure. Objectives 2/21/2016

Oregon Birth Outcomes, by Planned Birth Place and Attendant Pursuant to: HB 2380 (2011)

General and Objectives Clinical Skills for. Nursing Students in Maternity and Gynecology. Nursing Department

From Menses to Menopause: How Hormones Can Affect Blood Glucose Levels. Christine Day, RN, MS, CNS-BC Lake Superior College

The sensitive marker for glomerular filtration rate (GFR) Estimation of GFR from Serum Cystatin C:

Distortions in Fetal Growth Standards

Obstetric Cholestasis (itching liver disorder) Information for parents-to-be

Corporate Reimbursement Policy

Maternal serum free b-hcg and PAPP-A in fetal sex chromosome defects in the rst trimester

A test your patients can trust.

CONGENITAL HEART DISEASE

Mortality Assessment Technology: A New Tool for Life Insurance Underwriting

Diabetes Prevention in Latinos

THE BREASTFEEDING ANSWER BOOK CONTRACEPTION. To download electronic version. llli.org/babupdate

Family History and Diabetes. Practical Genomics for the Public Health Professional

Charts of fetal size: limb bones

The California Prenatal Screening Program

National Outcome Measures and National Performance Measures Kansas Maternal and Child Health Services Block Grant 2016 Application/2014 Annual Report

Screening for trisomy 21 by fetal tricuspid regurgitation, nuchal translucency and maternal serum free β-hcg and PAPP-A at to13+ 6 weeks

Are differences in methylation in cord blood DNA associated with prenatal exposure to alcohol?

2. Incidence, prevalence and duration of breastfeeding

TWEAK Score Questionnaire on Alcohol Use During Pregnancy

Physical activity before and during pregnancy and birth weight

CHLAMYDIA SCREENING IN WOMEN

A Strategic Plan for Improving Preconception Health and Health Care: Recommendations from the CDC Select Panel on Preconception Care

World Health Day Diabetes and RMNCAH in Africa: R for Reproductive Health

Rationale for replacing IVIG with Intralipid (IL) for immunological pregnancy loss

Prognosis of Very Large First-Trimester Hematomas

Rural Health Advisory Committee s Rural Obstetric Services Work Group

Cord Blood Erythropoietin and Markers of Fetal Hypoxia

Pilot linkage of NHS Numbers for Babies data with birth registrations

Guide to Biostatistics

Birth Defects Monitoring in Japan -Possible Effects of Environmental Endocrine Disrupters-

PRACTICE PROBLEMS FOR BIOSTATISTICS

Article. Anthony O. Odibo, MD, Christopher Riddick, Emmanuelle Pare, MD, David M. Stamilio, MD, MSCE, George A. Macones, MD, MSCE

Methodology for Safety Surveillance of Adverse Events Following Vaccination During Pregnancy

Neural Tube Defects - NTDs

Vaccines in Pregnancy MARK H. SAWYER, MD UCSD SCHOOL OF MEDICINE RADY CHILDREN S HOSPITAL SAN DIEGO

University of Maryland School of Medicine Master of Public Health Program. Evaluation of Public Health Competencies

Guidance for Preconception Care of Women with Thyroid Disease

Pregnancy and Substance Abuse

Introduction. Materials and Methods

Vaccination for Pregnant Women

Transcription:

First trimester determination of adverse pregnancy outcome Prof. Gordon C S Smith, MD, PhD Department of Obstetrics & Gynaecology, Cambridge University

In the first half of pregnancy, genetic control is dominant and gives rise to relatively narrow limits of variability of patterns of fetal growth Gluckman PD & Liggins GC. In Fetal Physiology and Medicine. 1984.

Early model of human fetal growth Genetically programmed early on Variability greatest in third trimester Bulk of weight gain in third trimester Implied a key role for maternal nutrition in the last third of pregnancy Led to multiple trials of dietary supplementation in late pregnancy

Low birth weight anomaly Women with poor diet are at increased risk of a low birth weight baby Dietary supplementation during the presumed phase of maximum fetal growth has a minimal effect on birth weight, except in conditions of starvation Susser, Am J Clin Nutr 1991;53:1384-1396

Hypothesis The intra-uterine conditions in early pregnancy determine, at least in part, the eventual birth weight

Prediction Measurements of fetal growth or placental function in early pregnancy may be predictive of eventual outcome

QMH cohort study All women attending for antenatal care at The Queen Mother s Hospital Glasgow 1985-1995 Included women had a scan in the first 12 weeks actual size Excluded women who had used oral contraception in last 3 months, irregular or non- 28 day menstrual cycle and not certain of date of LMP expected size Study group of 4229

Outcomes studied Examined both absolute birth weights, relative weights and gestational age Low birth weight (<2500g) Low birth weight at term (<2500g at or after 37 weeks gestation) Birth weight <5 th percentile for gestational age Preterm birth Extreme (24-32 weeks) Moderate (33-36 weeks)

Smith GCS et al, NEJM 1998;339:1817-22.

Smith GCS et al, NEJM 1998;339:1817-22.

Interpretation of results Poor growth of the fetus in the first trimester associated with increased risk of adverse outcome Could also indicate over-estimation of the age of the fetus i.e. ovulation occurred later than assumed Unlikely given restriction of women to those with a regular 28 day cycle

Alternative hypothesis Could be due to delayed ovulation Prolonged menstruation to conception interval associated with adverse outcome Based on second trimester US measurements Expected size of fetus based on LMP alone, no information on cycle duration, certainty of recall or hormonal contraception Gardosi & Francis, BJOG. 2000;107:228-37

Follow-up study Data from FASTER trial Large scale, multi-center, prospective cohort study of Down syndrome screening >30,000 women, 976 eligible women conceived using assisted reproductive technology method known date of conception with CRL measurement Repeated analysis and replicated result Bukowski, et al for FASTER consortium, Unpublished data

Smith GCS et al, NEJM 1998;339:1817-22.

Predictions from hypothesis Trophoblast function in the first trimester of pregnancy will differ comparing babies ultimately born of low birth weight with those of normal birth weight Potential for testing the hypothesis as maternal blood contains many trophoblast derived proteins which are minimally produced by other maternal tissues

CUBS Study Non-interventional, prospective cohort study designed to evaluate predictors of Down s syndrome Measured PAPP-A and free subunit of human chorionic gonadotrophin at 10-14 weeks using the Kryptor immunoassay analyzer Total cohort of approximately 13,000 women Study group of 8839 women with outcome data

Aims of analysis To relate risk of subsequent adverse obstetric outcomes to levels of PAPP-A and F hcg at 10-14 weeks

Methods PAPP-A and F hcg expressed as multiples of median (MOM) for gestation MOMs adjusted for maternal weight and smoking Outcomes related to deciles of PAPP-A and F hcg to establish trend Strength of association between lowest 5 th percentile and adverse outcomes

Statistics Outcome across deciles of PAPP-A and F hcg tested by chi squared test for trend Univariate and multivariate analysis of lowest 5 th percentile by logistic regression

PAPP-A levels in early pregnancy and the risk of adverse obstetric outcome Smith GCS et al JCEM 2002;87:1762-7

Free beta-hcg levels in early pregnancy and the risk of adverse obstetric outcome Smith GCS et al JCEM 2002;87:1762-7

Multivariate analysis PAPP-A F hcg Outcome OR* (95%CI) P= OR* (95%CI) P= BW <5 th percentile 2.9 (2.0-4.1) <0.001 1.3 (0.9-2.0) 0.15 Delivery 24-32 weeks 2.9 (1.6-5.5) 0.001 1.1 (0.5-2.7) 0.77 Delivery 33-36 weeks 2.4 (1.7-3.5) <0.001 0.5 (0.3-1.0) 0.04 Pre-eclampsia 2.3 (1.6-3.3) <0.001 1.1 (0.7-1.8) 0.64 *Adjusted for: BMI, height, smoking status, ethnicity, parity, maternal age, gestational age at the time of sampling, PAPP-A and F hcg Smith GCS et al JCEM 2002;87:1762-7

Summary of results No independent predictive effect of F hcg PAPP-A associated with all adverse outcomes F hcg was significantly associated with some outcomes but not independently of PAPP-A Different patterns of association between PAPP-A and different outcomes

PAPP-A and normal pregnancy Further analysis of cases where sampling wholly within first trimester Excluded all complicated pregnancies and confined analysis to term births Regression analysis (linear, logistic and proportional hazards) to determine associations between absolute birth weight, low birth weight and onset of labour

Risk of low birth weight at term Risk of a low birth weight baby at term explored using PAPP-A as a continuous variable (logistic regression) Odds ratio 0.2 (95% CI 0.1-0.6) Indicates that across the range of PAPP-A from the 1 st - 99 th percentile, risk of a low birth weight baby decreases by 80% Smith GCS et al, Nature 2002; 417:916.

Significance of fetal growth Poor fetal growth is a risk factor for antepartum stillbirth Poor fetal growth may be predictive of disease in later life

Antepartum stillbirth Most common cause of perinatal death Majority have no direct cause, but are associated with impaired growth Associations with second trimester biophysical measurements msafp and uterine artery Doppler Postulated may be due to impaired second wave of trophoblast invasion

Methods 1 Record linked CUBS study database with Scottish Morbidity Record 2 (SMR2, national database maternity hospital discharge data) and the Scottish Stillbirth & Infant Death Enquiry (national register of perinatal deaths) Limited to women assayed in first 10 weeks post-conception Linked database contained first trimester biochemistry and eventual outcome for 7934 singleton births between 24-43 weeks gestation Independent ascertainment of exposures and events Smith GCS et al, JAMA. 2004;292:2249-2254

Methods 2 PAPP-A and F hcg, expressed as MoMs Low defined as 5 th percentile (<0.4 MoM for PAPP-A) Smith GCS et al, JAMA. 2004;292:2249-2254

Results 1 No association between low PAPP-A ( 5 th percentile) and a range of maternal characteristics Age, marital status, socio-economic deprivation, ethnicity, smoking, parity, previous abortions, height and BMI (all P>0.05) Smith GCS et al, JAMA. 2004;292:2249-2254

Smith GCS et al, JAMA. 2004;292:2249-2254

Smith GCS et al, JAMA. 2004;292:2249-2254

Smith GCS et al, JAMA. 2004;292:2249-2254

Summary of results Very strong relationship between low PAPP-A and subsequent risk of stillbirth Association due to stillbirth related to placental dysfunction No placental stillbirths in upper 60% of PAPP-A Association specific Not due to maternal confounding No relationship with F hcg No relationship with other causes of stillbirth Smith GCS et al, JAMA. 2004;292:2249-2254

PAPP-A Produced in syncytiotrophoblast PAPP-A has protease activity on IGFBP-4 Low levels of PAPP-A lead to low levels of IGFBP-4 and likely decrease placental effects of IGF-II which would adversely affect growth Role supported by studies in mice: PAPP- A null mutants exhibit severe early onset IUGR (Conover et al, Development 2004;131:1187-1194)

Further studies on 1 st trimester trophoblast & obstetric outcome Follow-up studies using stored samples from cohort linked to Scottish maternity and perinatal death databases Nested-case control study of 1000 complicated pregnancies and 1000 controls Measured s-flt1, PlGF, IGF-1, IGF-2, IGFBP-1, IGFBP-3, Leptin and MMP-9

Relationship between first and second trimester predictors Elevated AFP and hcg associated with increased risk of stillbirth How does this relate to association with PAPP-A?

Interaction: P=0.03 Interaction: P=0.14 Smith et al, Obstet Gynecol 2006;107:161-166

Conclusions Fetal growth and risk of stillbirth determined in first trimester Synergistically predictive with second trimester markers Potential for sequential screening for stillbirth risk, comparable to Down s syndrome screening

Acknowledgements Dr Jill Pell, Consultant in Public Health, Greater Glasgow Health Board Information & Statistics Division of the NHS Scotland (James Boyd, David Walsh, Richard Dobbie), SMR2 & SMR1 data. Dr Jenny Crossley & Dr David Aitken, Department of Medical Genetics, Yorkhill, Glasgow (CUBS study) Mr John Fleming & Dr Margaret McNay, Department of Ultrasound, The Queen Mother s Hospital, Glasgow, Ultrasound database study